Jane Street’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.27M Sell
33,603
-1,056,813
-97% -$107M ﹤0.01% 4189
2025
Q4
$86.9M Buy
1,090,416
+492,961
+83% +$32.3M 0.01% 653
2025
Q3
$27.9M Sell
597,455
-692,620
-54% -$27.1M ﹤0.01% 1359
2025
Q2
$47.5M Buy
1,290,075
+952,673
+282% +$36.6M 0.01% 795
2025
Q1
$11.9M Buy
337,402
+273,471
+428% +$11.1M ﹤0.01% 1784
2024
Q4
$2.8M Sell
63,931
-116,966
-65% -$5.9M ﹤0.01% 3571
2024
Q3
$8.2M Sell
180,897
-199,697
-52% -$8.7M ﹤0.01% 2146
2024
Q2
$14.8M Buy
380,594
+251,127
+194% +$9.39M ﹤0.01% 1597
2024
Q1
$4.17M Sell
129,467
-66,765
-34% -$1.98M ﹤0.01% 2895
2023
Q4
$5.63M Sell
196,232
-5,764
-3% -$139K ﹤0.01% 2692
2023
Q3
$5.59M Buy
201,996
+88,694
+78% +$2.63M ﹤0.01% 2461
2023
Q2
$3.03M Buy
113,302
+57,008
+101% +$1.4M ﹤0.01% 3473
2023
Q1
$1.22M Buy
56,294
+46,301
+463% +$1.14M ﹤0.01% 4651
2022
Q4
$238K Sell
9,993
-11,034
-52% -$235K ﹤0.01% 7396
2022
Q3
$415K Buy
21,027
+5,443
+35% +$120K ﹤0.01% 7022
2022
Q2
$304K Buy
15,584
+3,334
+27% +$64.9K ﹤0.01% 7594
2022
Q1
$312K Buy
+12,250
New +$267K ﹤0.01% 8336
2021
Q2
Sell
-7,122
Closed -$327K 10313
2021
Q1
$327K Buy
+7,122
New +$319K ﹤0.01% 7558

Other funds holding RVMD

Jane Street's RVMD Position: Q1 2026 in Review

Jane Street reduced its Revolution Medicines (RVMD) stake by 97% in Q1 2026, selling an estimated $107M and leaving 33,603 shares worth $3.27M. The position accounts for ﹤0.01% of the portfolio, ranked #4189.

Jane Street first reported a position in RVMD in Q1 2021 and has held it in 18 quarters since. The position peaked at $86.9M in Q4 2025. 513 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Jane Street held 33,603 shares of Revolution Medicines worth $3.27M as of Q1 2026.
  • Jane Street sold 1,056,813 Revolution Medicines shares in Q1 2026, an estimated $107M.
  • Revolution Medicines made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4189 holding.
  • Jane Street first reported a position in Revolution Medicines in Q1 2021 and has held it in 18 quarters since.
  • Jane Street's Revolution Medicines position peaked at $86.9M in Q4 2025.
  • 513 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.